Targeting the Pim Kinases in Multiple Myeloma

Blood Cancer Journal - United States
doi 10.1038/bcj.2015.46
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Biological Effects of the Pim Kinase Inhibitor, SGI-1776, in Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Targeting the Phosphatidylinositol 3-Kinase Pathway in Multiple Myeloma

Clinical Cancer Research
Cancer ResearchOncology
2007English

Targeting the PIM Protein Kinases for the Treatment of a T-Cell Acute Lymphoblastic Leukemia Subset

Oncotarget
Oncology
2017English

The Therapeutic Potential of Cell Cycle Targeting in Multiple Myeloma

Oncotarget
Oncology
2017English

Targeting the Fanconi Anemia/Brca Pathway Circumvents Drug Resistance in Multiple Myeloma

Cancer Research
Cancer ResearchOncology
2009English

MNK Kinases Facilitate C-Myc IRES Activity in Rapamycin-Treated Multiple Myeloma Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

Targeting MK2 Is a Novel Approach to Interfere in Multiple Myeloma

Frontiers in Oncology
Cancer ResearchOncology
2019English

Clinical Implications of Targeting XPO1-Mediated Nuclear Export in Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2018English

Synthesis and Evaluation of Novel Inhibitors of Pim-1 and Pim-2 Protein Kinases

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy